New comment co-authored by Jan-Eric Litton: Bridging the translational innovation gap through good biomarker practice

Jan-Eric Litton is one of the authors of a comment recently published in Nature Reviews Drug Discovery. Titled Bridging the Translational Innovation Gap Through Good Biomarker Practice, the comment highlights that few biomarkers progress from discovery to becoming validated tools or diagnostics.

The authors describe how three European biomedical research infrastructures — EATRIS-ERIC (focussing on translational medicine), BBMRI-ERIC (focussing on biobanking) and ELIXIR (focussing on data sharing) — are paving the way to developing and sharing best practices for biomarker validation in order to bridge this gap.

Click here for an article preview and to view different access options.